NO20072806L - Aryloksy-substituerte benzimidazolderivater - Google Patents
Aryloksy-substituerte benzimidazolderivaterInfo
- Publication number
- NO20072806L NO20072806L NO20072806A NO20072806A NO20072806L NO 20072806 L NO20072806 L NO 20072806L NO 20072806 A NO20072806 A NO 20072806A NO 20072806 A NO20072806 A NO 20072806A NO 20072806 L NO20072806 L NO 20072806L
- Authority
- NO
- Norway
- Prior art keywords
- nitrogen
- hydrogen
- integer
- carbon
- aryloxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004319339 | 2004-11-02 | ||
JP2005178628 | 2005-06-17 | ||
PCT/JP2005/020483 WO2006049304A1 (ja) | 2004-11-02 | 2005-11-01 | アリールオキシ置換ベンズイミダゾール誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20072806L true NO20072806L (no) | 2007-07-27 |
Family
ID=36319300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20072806A NO20072806L (no) | 2004-11-02 | 2007-06-01 | Aryloksy-substituerte benzimidazolderivater |
Country Status (17)
Country | Link |
---|---|
US (1) | US7932394B2 (ja) |
EP (1) | EP1810969B1 (ja) |
JP (1) | JP5036316B2 (ja) |
KR (1) | KR20070083939A (ja) |
CN (1) | CN101094847B (ja) |
AU (1) | AU2005301608B2 (ja) |
BR (1) | BRPI0517232A (ja) |
CA (1) | CA2586056C (ja) |
CR (1) | CR9078A (ja) |
EC (1) | ECSP077422A (ja) |
IL (1) | IL182679A0 (ja) |
MA (1) | MA29043B1 (ja) |
MX (1) | MX2007005289A (ja) |
NO (1) | NO20072806L (ja) |
NZ (1) | NZ554440A (ja) |
RU (1) | RU2398773C2 (ja) |
WO (1) | WO2006049304A1 (ja) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060105872A (ko) * | 2003-12-29 | 2006-10-11 | 반유 세이야꾸 가부시끼가이샤 | 신규한 2-헤테로아릴 치환된 벤즈이미다졸 유도체 |
EP1905769B1 (en) * | 2005-07-13 | 2017-03-29 | Msd K.K. | Heterocycle-substituted benzimidazole derivative |
TW200732296A (en) * | 2005-12-15 | 2007-09-01 | Astrazeneca Ab | Novel compounds |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
WO2008081204A1 (en) | 2007-01-04 | 2008-07-10 | Prosidion Limited | Piperidine gpcr agonists |
EP2188274A4 (en) * | 2007-08-03 | 2011-05-25 | Boehringer Ingelheim Int | VIRAL POLYMERASE HEMMER |
ES2493593T3 (es) | 2007-11-12 | 2014-09-12 | Msd K.K. | Derivado de heteroariloxi quinazolina |
US8476257B2 (en) | 2007-12-19 | 2013-07-02 | Boehringer Ingelheim International Gmbh | Viral polymerase inhibitors |
WO2009082152A2 (en) | 2007-12-20 | 2009-07-02 | Lg Life Sciences Ltd. | Glucokinase activators and pharmaceutical compositions containing the same as an active ingredient |
JP2012500181A (ja) | 2008-08-15 | 2012-01-05 | Msd株式会社 | アセチルピロリジニルインドール誘導体 |
EP2328892B1 (en) * | 2008-08-29 | 2013-01-16 | Msd K.K. | Oxotetrahydrofuran-2-yl-benzimidazole derivative |
CN101607923B (zh) * | 2009-07-21 | 2012-12-19 | 焦宁 | 芳基腈类化合物或其衍生物及其合成方法和应用 |
WO2012062210A1 (en) * | 2010-11-09 | 2012-05-18 | Zhejiang Beta Pharma Inc. | Compound for increasing kinase active and application thereof |
US20120258891A1 (en) | 2011-04-07 | 2012-10-11 | Nimblegen Systems Gmbh | Diarylsulfide backbone containing photolabile protecting groups |
WO2015161016A1 (en) * | 2014-04-17 | 2015-10-22 | Merck Sharp & Dohme Corp. | Bicyclic cgrp receptor antagonists |
TWI636045B (zh) * | 2015-11-17 | 2018-09-21 | 美商維愛美製藥公司 | 4-((6-(2-(2,4-二氟苯基)-1,1-二氟-2-氧代乙基)吡啶-3-基)氧基)苄腈以及其製造方法 |
BR112018009920A2 (pt) * | 2015-11-17 | 2018-11-13 | Dow Agrosciences Llc | 4-((6-(2-(2,4-difluorfenil)-1,1-diflúor-2-hidróxi-3-(1h-1,2,4-triazol-1-il)propil)piridin-3-il)óxi)benzonitrila e processos de preparação |
TWI636049B (zh) * | 2015-11-17 | 2018-09-21 | 美商維愛美製藥公司 | 製備4-((6-(2-(2,4-二氟苯基)-1,1-二氟-2-羥基-3-(1h-1,2,4-三唑-1-基)丙基)吡啶-3-基)氧基)苄腈之方法 |
WO2018130537A1 (en) * | 2017-01-10 | 2018-07-19 | ETH Zürich | Cell-protective compounds and their use |
KR20240035820A (ko) | 2021-07-09 | 2024-03-18 | 플렉시움 인코포레이티드 | Ikzf2를 조절하는 아릴 화합물 및 약학 조성물 |
WO2024033677A1 (en) * | 2022-08-09 | 2024-02-15 | Faculdade De Farmácia Da Universidade De Lisboa | One-pot method for the synthesis of 3-acetamido-furfural from n-acetylglucosamine |
JP7356203B1 (ja) | 2023-08-03 | 2023-10-04 | Towa Corporation 株式会社 | WD and tetratricopeptide repeats 1遺伝子発現亢進用医薬組成物及び食品組成物 |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3598123A (en) | 1969-04-01 | 1971-08-10 | Alza Corp | Bandage for administering drugs |
US3630200A (en) | 1969-06-09 | 1971-12-28 | Alza Corp | Ocular insert |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
DK337086A (da) * | 1985-08-12 | 1987-02-13 | Hoffmann La Roche | Benzimidazolderivater |
IL102183A (en) * | 1991-06-27 | 1999-11-30 | Takeda Chemical Industries Ltd | The heterocyclic compounds are converted into biphenyl groups, their production and the pharmaceutical compositions containing them |
US5349045A (en) | 1993-01-26 | 1994-09-20 | United States Surgical Corporation | Polymer derived from cyclic amide and medical devices manufactured therefrom |
PE92198A1 (es) | 1996-08-01 | 1999-01-09 | Banyu Pharma Co Ltd | Derivados de 1,4-piperidina disustituida que contienen fluor |
US20020032330A1 (en) * | 1996-12-24 | 2002-03-14 | Yutaka Nomura | Propionic acid derivatives |
JPH10306076A (ja) | 1997-03-06 | 1998-11-17 | Nippon Chemiphar Co Ltd | プロピオン酸誘導体 |
US6162804A (en) * | 1997-09-26 | 2000-12-19 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
ATE399766T1 (de) | 2000-10-20 | 2008-07-15 | Eisai R&D Man Co Ltd | Stickstoff enthaltende aromatische heterozyklen |
AU2190202A (en) | 2000-12-06 | 2002-06-18 | Hoffmann La Roche | Fused heteroaromatic glucokinase activators |
US6433188B1 (en) * | 2000-12-06 | 2002-08-13 | Wendy Lea Corbett | Fused heteroaromatic glucokinase activators |
US6958340B2 (en) | 2001-08-01 | 2005-10-25 | Merck & Co., Inc. | Tyrosine kinase inhibitors |
JP2004123711A (ja) | 2002-08-02 | 2004-04-22 | Sankyo Co Ltd | レゾルシノール誘導体 |
WO2004013109A1 (ja) | 2002-08-02 | 2004-02-12 | Sankyo Company, Limited | レゾルシノール誘導体 |
JP2004067629A (ja) * | 2002-08-09 | 2004-03-04 | Yamanouchi Pharmaceut Co Ltd | ミトコンドリア機能活性化剤及び新規なベンゾイミダゾール誘導体 |
US7629362B2 (en) | 2003-02-13 | 2009-12-08 | Banyu Pharmaceutical Co., Ltd. | 2-pyridine carboxamide derivatives |
KR20060105872A (ko) * | 2003-12-29 | 2006-10-11 | 반유 세이야꾸 가부시끼가이샤 | 신규한 2-헤테로아릴 치환된 벤즈이미다졸 유도체 |
-
2005
- 2005-11-01 WO PCT/JP2005/020483 patent/WO2006049304A1/ja active Application Filing
- 2005-11-01 EP EP05803447.1A patent/EP1810969B1/en active Active
- 2005-11-01 CN CN2005800456884A patent/CN101094847B/zh not_active Expired - Fee Related
- 2005-11-01 BR BRPI0517232-2A patent/BRPI0517232A/pt not_active IP Right Cessation
- 2005-11-01 CA CA2586056A patent/CA2586056C/en not_active Expired - Fee Related
- 2005-11-01 JP JP2006542472A patent/JP5036316B2/ja not_active Expired - Fee Related
- 2005-11-01 NZ NZ554440A patent/NZ554440A/en not_active IP Right Cessation
- 2005-11-01 AU AU2005301608A patent/AU2005301608B2/en not_active Ceased
- 2005-11-01 US US11/666,555 patent/US7932394B2/en active Active
- 2005-11-01 MX MX2007005289A patent/MX2007005289A/es active IP Right Grant
- 2005-11-01 KR KR1020077010065A patent/KR20070083939A/ko not_active Application Discontinuation
- 2005-11-01 RU RU2007120519/04A patent/RU2398773C2/ru not_active IP Right Cessation
-
2007
- 2007-04-19 IL IL182679A patent/IL182679A0/en unknown
- 2007-04-20 CR CR9078A patent/CR9078A/es not_active Application Discontinuation
- 2007-04-27 EC EC2007007422A patent/ECSP077422A/es unknown
- 2007-05-28 MA MA29946A patent/MA29043B1/fr unknown
- 2007-06-01 NO NO20072806A patent/NO20072806L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2007120519A (ru) | 2008-12-10 |
EP1810969A4 (en) | 2011-05-25 |
RU2398773C2 (ru) | 2010-09-10 |
JP5036316B2 (ja) | 2012-09-26 |
CN101094847B (zh) | 2011-06-15 |
AU2005301608B2 (en) | 2012-09-13 |
BRPI0517232A (pt) | 2008-10-07 |
US7932394B2 (en) | 2011-04-26 |
MX2007005289A (es) | 2007-07-19 |
MA29043B1 (fr) | 2007-11-01 |
KR20070083939A (ko) | 2007-08-24 |
IL182679A0 (en) | 2007-09-20 |
CA2586056A1 (en) | 2006-05-11 |
CA2586056C (en) | 2012-03-13 |
NZ554440A (en) | 2010-01-29 |
US20080125429A1 (en) | 2008-05-29 |
WO2006049304A1 (ja) | 2006-05-11 |
AU2005301608A1 (en) | 2006-05-11 |
EP1810969A1 (en) | 2007-07-25 |
ECSP077422A (es) | 2007-05-30 |
CN101094847A (zh) | 2007-12-26 |
JPWO2006049304A1 (ja) | 2008-05-29 |
EP1810969B1 (en) | 2013-08-07 |
CR9078A (es) | 2007-10-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20072806L (no) | Aryloksy-substituerte benzimidazolderivater | |
NO20066015L (no) | Fuserte heterosykliske forbindelser | |
TW200736363A (en) | Material for organic electroluminescent device and organic electroluminescent device | |
MXPA05008619A (es) | Derivados novedosos de 2-piridincarboxamida. | |
NO20091793L (no) | 2-pyridinkarboksamidderivat med GK-aktiverende virkning | |
MXPA05009059A (es) | Derivados de heteroarilcarbamoilbenceno. | |
NO20075312L (no) | N-(N-sulfonylaminometyl)cyklopropankarboksamidderivater nyttige ved smertebehandling | |
TW200745032A (en) | Novel heterobicyclic derivatives | |
ECSP066682A (es) | Derivado novedoso de bencimidazol 2-heteroaril-substituido | |
NO20083514L (no) | Heterobicykliske sulfonamidderivater for behandling av diabetes | |
NO20061076L (no) | (Tio)karbamoylsykloheksanderivater som D3/D2 -reseptorantagonister | |
NO20064089L (no) | Kondensert ring 4-oksopyrimidinderivat | |
NO20092770L (no) | Nye aminopyrimidinderivater som PLK1-inhibitorer | |
NO20072632L (no) | Oksadiazolderivater som DGAT-inhibitorer | |
NO20082388L (no) | Heteroaryl substituerte piperidinderivater som L-CPT1 inhibitorer | |
MX2009010024A (es) | Nuevo compuesto de adenina. | |
WO2005097129A3 (en) | 6-azaindole compound | |
MY142807A (en) | Benzimidazole derivative and use thereof. | |
NO20075082L (no) | Pyridin-3-karboksamidderivater som CB1-inversagonister | |
TN2010000091A1 (en) | Substituted pyrazole derivative | |
SG163617A1 (en) | Macrocyclic inhibitors of hepatitis c virus | |
NO20054852L (no) | GFAT inhibitorer | |
MX2009012885A (es) | Nuevo derivado de 1,2,3,4-tetrahidroquinoxalina que tiene, como sustituyente, grupo fenilo que tiene estructura de ester de acido sulfonico o estructura de amida de acido sulfonico introducida en este, y tiene actividad de enlace al receptor de gluco | |
NO20090952L (no) | N-(aminoheteroaryl) - lh - indol-2-karboksamidderivater og fremstilling og terapeutisk anvendelse derav | |
TW200745118A (en) | Macrocylic inhibitors of hepatitis C virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |